ANRO vs HCA · $60.1M cap vs P/E 17, rev $75.60B
Alto Neuroscience, Inc. (ANRO) versus HCA Holdings Inc (HCA) — a side-by-side from cached financials, not a winner call.
Alto Neuroscience, Inc. (ANRO) is a biotechnology company listed on US.
HCA Holdings Inc (HCA) is a medical care facilities company listed on US.
ANRO does not have a complete income-statement cache yet.
Latest reported HCA revenue for 2025-12-31 was $75.60B. Net income was $6.78B. Revenue was up 7.1% from 2024-12-31 to 2025-12-31. HCA currently screens at market cap $91.01B and trailing P/E 16.8.
ANRO currently screens at market cap $60.1M. HCA currently screens at market cap $91.01B and trailing P/E 16.8.
Not investment advice. Open the ANRO and HCA stock pages for the full models.
Not investment advice.